| RS1293342751 |
COL11A2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1293351659 |
PGM3
|
Health Risk |
Pathogenic |
Immunodeficiency 23, Immunodeficiency 23 |
| RS1293371764 |
VPS13A
|
Health Risk |
Likely pathogenic |
— |
| RS1293372026 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS1293390303 |
EYA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nonsyndromic hearing loss 10, Autosomal dominant nonsyndromic hearing loss 10 |
| RS1293404628 |
FKRP
|
Health Risk |
Pathogenic/Likely pathogenic |
Walker-Warburg congenital muscular dystrophy, Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies) |
| RS1293420539 |
EYA4
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 1J, Dilated cardiomyopathy 1J |
| RS1293427858 |
SGSH
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-A |
| RS1293448832 |
LRRK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1293450628 |
MED23
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal recessive 18 |
| RS1293467045 |
MOS
|
Health Risk |
Likely pathogenic |
Oocyte/zygote/embryo maturation arrest 20, Oocyte/zygote/embryo maturation arrest 20 |
| RS1293471595 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS1293477494 |
F7
|
Health Risk |
Pathogenic |
Congenital factor VII deficiency, Congenital factor VII deficiency |
| RS1293481687 |
TMEM67
|
Health Risk |
Likely pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS1293482406 |
PHEX
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1293496023 |
CAPN3
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Muscular dystrophy |
| RS1293504009 |
CPT1A
|
Health Risk |
Likely pathogenic |
Carnitine palmitoyl transferase 1A deficiency, Carnitine palmitoyl transferase 1A deficiency |
| RS1293512916 |
AIP
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Somatotroph adenoma |
| RS1293515155 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1293522591 |
SZT2
|
Health Risk |
Pathogenic |
— |
| RS1293528130 |
SLC25A38
|
Health Risk |
Pathogenic |
Sideroblastic anemia 2, Sideroblastic anemia 2 |
| RS1293549383 |
ATP7B
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Wilson disease |
| RS1293600145 |
MTRR
|
Health Risk |
Pathogenic/Likely pathogenic |
Methylcobalamin deficiency type cblE, Neural tube defects |
| RS1293617484 |
CHEK2
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1293618149 |
COL9A3
|
Health Risk |
Pathogenic |
— |
| RS1293619630 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome, Retinitis pigmentosa 39 |
| RS1293620319 |
GNAT1
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1293654827 |
RP1
|
Health Risk |
Pathogenic |
— |
| RS1293658262 |
IGSF1
|
Health Risk |
Likely pathogenic |
— |
| RS1293658639 |
SUMF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Multiple sulfatase deficiency, Multiple sulfatase deficiency |
| RS1293675104 |
MAP3K20
|
Health Risk |
Pathogenic |
Myopathy, centronuclear |
| RS1293701269 |
FLNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Oto-palato-digital syndrome, type II |
| RS1293713568 |
CACNA2D4
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1293733346 |
CDH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1293736497 |
COL6A2
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS1293743818 |
TUBB1
|
Health Risk |
Pathogenic |
Macrothrombocytopenia, isolated |
| RS1293760338 |
TCIRG1
|
Health Risk |
Pathogenic |
Autosomal recessive osteopetrosis 1, Autosomal recessive osteopetrosis 1 |
| RS1293775732 |
CLDN16
|
Health Risk |
Likely pathogenic |
Renal hypomagnesemia 5 with ocular involvement, Renal hypomagnesemia 5 with ocular involvement |
| RS1293789661 |
CLCN2
|
Health Risk |
Pathogenic |
Familial hyperaldosteronism type II, Epilepsy |
| RS1293819249 |
DNAH11
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1293824666 |
LAMA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital muscular dystrophy due to partial LAMA2 deficiency, LAMA2-related muscular dystrophy |
| RS1293826790 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1293831035 |
MRE11
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia-like disorder |
| RS1293851600 |
NF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 2 |
| RS1293852552 |
CNGA3
|
Health Risk |
Conflicting classifications of pathogenicity |
Achromatopsia 2, Achromatopsia 2 |
| RS1293857367 |
DYSF
|
Health Risk |
Likely pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Miyoshi muscular dystrophy 1 |
| RS1293893301 |
ABCB4
|
Health Risk |
Pathogenic |
Progressive familial intrahepatic cholestasis type 3, Progressive familial intrahepatic cholestasis type 3 |
| RS1293898535 |
BPTF
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1293901426 |
MLIP
|
Health Risk |
Pathogenic |
Myopathy with myalgia, increased serum creatine kinase |
| RS1293906490 |
DNAH5
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1293908408 |
DLL3
|
Health Risk |
Pathogenic |
— |
| RS1293915082 |
CHST14
|
Health Risk |
Pathogenic/Likely pathogenic |
Ehlers-Danlos syndrome, musculocontractural type |
| RS1293916143 |
SETD2
|
Health Risk |
Likely pathogenic |
Acute megakaryoblastic leukemia without down syndrome, Acute megakaryoblastic leukemia without down syndrome |
| RS1293925787 |
RINT1
|
Health Risk |
Pathogenic |
— |
| RS1293936199 |
MBD5
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 1 |
| RS1293947350 |
GRIN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant |
| RS1293971731 |
SLC26A4
|
Health Risk |
Likely pathogenic |
Rare genetic deafness, Autosomal recessive nonsyndromic hearing loss 4 |
| RS1293979204 |
HCN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS1293996279 |
EYS
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 25, Retinal dystrophy |
| RS1294025132 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypobetalipoproteinemia 1, Hypercholesterolemia |
| RS1294029121 |
TRIP11
|
Health Risk |
Pathogenic |
Achondrogenesis, type IA |
| RS1294044448 |
SLC5A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial renal glucosuria, Familial renal glucosuria |
| RS1294045208 |
NSUN2
|
Health Risk |
Pathogenic |
— |
| RS1294054951 |
BUB1B
|
Health Risk |
Pathogenic |
Mosaic variegated aneuploidy syndrome 1, Mosaic variegated aneuploidy syndrome 1 |
| RS1294058368 |
TOPORS
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1294061925 |
CTNNA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Patterned macular dystrophy 2 |
| RS1294100541 |
EXOC6B
|
Health Risk |
Pathogenic |
Spondyloepimetaphyseal dysplasia with joint laxity, type 3 |
| RS1294102203 |
CHD7
|
Health Risk |
Conflicting classifications of pathogenicity |
CHARGE syndrome, Inborn genetic diseases |
| RS1294102415 |
SACS
|
Health Risk |
Pathogenic/Likely pathogenic |
Spastic paraplegia, Charlevoix-Saguenay spastic ataxia |
| RS1294116781 |
MSH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1294136105 |
PRDM16
|
Health Risk |
Conflicting classifications of pathogenicity |
Left ventricular noncompaction 8, Left ventricular noncompaction 8 |
| RS1294139623 |
SMARCAL1
|
Health Risk |
Pathogenic |
Schimke immuno-osseous dysplasia, Schimke immuno-osseous dysplasia |
| RS1294150954 |
KCND3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Neurodevelopmental delay |
| RS1294168838 |
MLYCD
|
Health Risk |
Pathogenic |
Deficiency of malonyl-CoA decarboxylase, Deficiency of malonyl-CoA decarboxylase |
| RS1294210561 |
HPD
|
Health Risk |
Pathogenic |
Hawkinsinuria, Tyrosinemia type III |
| RS1294213097 |
FLNC
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Hypertrophic cardiomyopathy 26 |
| RS1294215890 |
ITGB4
|
Health Risk |
Conflicting classifications of pathogenicity |
Junctional epidermolysis bullosa with pyloric atresia, Junctional epidermolysis bullosa with pyloric atresia |
| RS1294221028 |
MCFD2
|
Health Risk |
Pathogenic |
Factor 5 and Factor VIII, combined deficiency of |
| RS12942386 |
MKS1
|
Health Risk |
Likely pathogenic |
Meckel-Gruber syndrome, Joubert syndrome |
| RS1294240905 |
SGSH
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Mucopolysaccharidosis |
| RS1294262903 |
SLC26A2
|
Health Risk |
Pathogenic |
Achondrogenesis, type IB |
| RS1294265690 |
COL7A1
|
Health Risk |
Pathogenic |
Recessive dystrophic epidermolysis bullosa, Recessive dystrophic epidermolysis bullosa |
| RS1294268789 |
PEX1
|
Health Risk |
Pathogenic |
Zellweger spectrum disorders, Zellweger spectrum disorders |
| RS1294269013 |
ALDH5A1
|
Health Risk |
Pathogenic |
Succinate-semialdehyde dehydrogenase deficiency, Succinate-semialdehyde dehydrogenase deficiency |
| RS1294270968 |
MBD5
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 1 |
| RS1294272918 |
SHANK3
|
Health Risk |
Pathogenic/Likely pathogenic |
Autistic behavior, Phelan-McDermid syndrome |
| RS1294289633 |
ERCC6
|
Health Risk |
Pathogenic |
— |
| RS1294295448 |
FAM161A
|
Health Risk |
Pathogenic |
— |
| RS1294326404 |
LDLRAP1
|
Health Risk |
Likely pathogenic |
Hypercholesterolemia, familial |
| RS1294330944 |
CERKL
|
Health Risk |
Pathogenic |
— |
| RS1294340795 |
CNGB3
|
Health Risk |
Pathogenic |
— |
| RS1294360179 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1294369944 |
SLC45A2
|
Health Risk |
Pathogenic |
Oculocutaneous albinism type 4, Oculocutaneous albinism type 4 |
| RS1294383261 |
ARV1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 38 |
| RS1294387014 |
MAGI2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1294402003 |
CEP290
|
Health Risk |
Pathogenic/Likely pathogenic |
Nephronophthisis, Joubert syndrome |
| RS1294405938 |
TRMU
|
Health Risk |
Conflicting classifications of pathogenicity |
TRMU-related disorder, TRMU-related disorder |
| RS1294413650 |
HSPG2
|
Health Risk |
Likely pathogenic |
Schwartz-Jampel syndrome, Lethal Kniest-like syndrome |
| RS1294424179 |
CDK4
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial melanoma, Melanoma |
| RS1294428066 |
CSPP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Joubert syndrome 21, Meckel-Gruber syndrome |